一个小分子调节器影响时钟相关的伪响应调节器 7 量
Takahiro N Uehara1, Saori Takao2, Hiromi Matsuo3
1Graduate School of Science, Nagoya University, Furo-cho, Chikusa, Nagoya, 464-8602 Japan.
发现了一种新型分子,TU-892,通过降低PRR7蛋白水平来延长植物昼夜钟周期. 这影响了关键的时钟基因表达,为植物计时机制提供了新的见解.
科学领域:
- 植物生物学 植物生物学
- 时间生物学 时间生物学
- 分子遗传学 分子遗传学
背景情况:
- 循环时钟通过转录-翻译反循环 (TTFLs) 调节植物中的日常节奏.
- 关键成分包括PSUEDO-RESPONSE REGULATOR (PRR) 蛋白质,它们充当转录抑制剂.
- 了解这些循环的调节器对于破译工厂时钟机制至关重要.
研究的目的:
- 为了识别植物昼夜钟的新型小分子调节剂.
- 调查已识别的调节器的作用机制,特别是TU-892.
- 阐明PRR7在植物生理时钟路径中的作用.
主要方法:
- 将一万个化合物的化学库与一个Arabidopsis钟记者线进行选.
- 使用定量PCR进行基因表达分析,以评估mRNA水平.
- 蛋白质水平分析以确定对PRR7和其他PRR蛋白的影响.
- 在PRR7受损突变体中分析TU-892的影响.
主要成果:
- 合成的小分子TU-892被确定为一种延长周期的化合物.
- 在TU-892治疗上调调节了CIRCADIAN CLOCK-ASSOCIATED 1 (CCA1) 的mRNA表达.
- TU-892特异性降低了PRR7蛋白水平,这是CCA1.1的抑制剂.
- 图-892对CCA1的影响取决于PRR7,因为它在PRR7突变中被减弱.
结论:
- TU-892代表了一种新型的植物昼夜时钟调节器.
- 该分子通过降低PRR7蛋白水平来起作用,从而影响CCA1的表达.
- 这项研究为研究植物昼夜生物和PRR蛋白的作用提供了一个新的工具.
更多相关视频
06:50The Use of Mouse Splenocytes to Assess Pathogen-associated Molecular Pattern Influence on Clock Gene Expression
Published on: July 24, 2018
07:42Rapid Analysis of Circadian Phenotypes in Arabidopsis Protoplasts Transfected with a Luminescent Clock Reporter
Published on: September 17, 2016
相关概念视频
Circadian Rhythms and Gene Regulation
Global Regulatory Systems
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Biological Clocks and Seasonal Responses
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
